![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](bi2322contents.gif)
Acta Cryst. (2009). E65, o14 [ doi:10.1107/S160053680803986X ]
Abstract: The title compound, C17H25ClN3O3+·Cl-·H2O, is a monohydrated hydrochloride salt of a new derivative of mosapride, which is a pharmaceutical compound possessing gastrointestinal pro-kinetic activity. The chloride anion accepts hydrogen bonds from the NH group of the pyrrolooxazine fused-ring system and from the amine group, and the water molecules form hydrogen bonds that bridge between the chloride anion and the C=O bond of the amide.
Online 3 December 2008
Copyright © International Union of Crystallography
IUCr Webmaster